—  SPECIALTY CONFERENCE  —

BONE AND SOFT TISSUE PATHOLOGY

Case 3 - Kaposiform hemangioendothelioma

Sharon W. Weiss
Emory University Hospital
Atlanta, Georgia


Click on each slide thumbnail image for an enlarged view
Clinical History:
The patient was a 15 year old male who presented with a 3 month history of a painful right thigh mass. No other associated laboratory abnormalities were noted. Following an incisional biopsy a more extensive excision was performed. The gross specimen consisted of skin, subcutaneous tissue and an underlying portion of sartorius muscle. The latter was involved by a partially hemorrhagic infiltrating lesion. Your sections are taken from the excision specimen.


Case 3 - Figure 1 - Lobulated appearance of the neoplasm.

Case 3 - Figure 2 - Densely cellular spindle cell proliferation


Case 3 - Figure 3 - Slit-like spaces are present between the spindle cells and some contain red blood cells.

Case 3 - Figure 4 - Overt vascular formation is present in focal areas of the neoplasm.

The kaposiform hemangioendothelioma (KHE)1 is a vascular tumor of intermediate malignancy which has been reported under a number of terms including Kaposi-like hemangioendothelioma2  and hemangioma with Kaposi-like features. Although these lesions were probably misclassified as juvenile hemangiomas in the past, there are substantial reasons to consider them distinct from the usual juvenile (cellular) hemangioma (CH) of infancy and Kaposi's sarcoma (KS).

KHE typically presents during childhood or teenage years as a superficial or deep lesion. Superficial lesions appear as violaceous plaques which contrast with the red polypoid appearance of classic CH. Large lesions or those in deep locations may also be associated with consumption coagulopathy and Kasabach Merritt syndrome which develops in about 50% of patients in our experience. In fact, it now appears that most cases of Kasabach Merritt syndrome, are associated with KHE and not with ordinary capillary or cavernous hemangiomas, as was once thought.3  A subset of KHE may be associated with lymphangiomatosis. Histologically KHE consists of irregular nodular aggregates of tumor often evoking a dense sclerosis. About two thirds are surrounded by dilated lymphatic vessels. Within the nodules the tumor modulates between areas resembling a capillary hemangioma and Kaposi's sarcoma. A characteristic feature of KHE is the presence of glomeruloid nests of rounded cells with abundant eosinophilic cytoplasm, presumably, endothelium and/or pericytes, which contain fine granules of hemosiderin and hyaline globules. Red blood cells and fibrin thrombi can be identified between these cells. Atypia and mitotic activity is usually minimal.

Immunohistochemically the neoplastic endothelium express CD31, CD34 and VEGFR3 but not GLUT1 (an oxygen transport protein that is strongly expressed in CH). Actin immunostains (SMA) highlight a population of cells, presumably pericytes, which also participate in these lesions.1,4  The presence of VEGFR3 is a feature that this tumor has in common with other intermediate vascular tumors of childhood (cf. Dabska-retiform hemangioendothelioma) whereas the lack of GLUT1 serves to distinguish it from CH. HHV8 which is consistently present in Kaposi's sarcoma, has not been detected in 3 cases of KHE studied by RT-PCR.4 

Although these tumors are far more life threatening than ordinary hemangiomas, morbidity and mortality is directly linked to the paraneoplastic complications of the disease. In the largest study to date comprising 21 cases with follow up information, 3 died of disease.4  Two succumbed to Kasabach Merritt syndrome and 1 to the complications of lymphangiomatosis. Ten patients were alive without residual disease and 8 were alive with disease. Only 1 patient has developed local soft tissue and regional lymph node metastasis,4,5  but none has developed distant metastasis. Thus the challenge in these cases is not only to eradicate the tumor but to support patients who develop life threatening hemorrhage. Some success has been reported using interferon alpha 2a and multimodality chemotherapy.

The differential diagnosis of these tumors include CH, KS, and acquired tufted hemangioma. CH, usually presenting shortly after birth, as a rapidly growing red nodules, are composed of more orderly nodular aggregates of small capillary sized vessels that surround a central feeding vessel. In the early proliferative stage these vessels are poorly canalized andare mitotically active. With maturation the vessels become canalized less mitotically active. However, regardless of stage of evolution the cells consistently express GLUT1 in contrast to KHE. Kaposi's sarcoma, of course, is almost exclusively a tumor of adults although in Africa the lympadenopathic forms occurs in children. Typically the lesions consist of uniformly spindled cells surrounded by a chronic inflammatory infiltrate and thick walled vessels. Virtually all cases are associated with HHV8 and none with Kasabach Merritt syndrome. Acquired tufted hemangioma is histologically similar to KH and, in fact, may simply represent a variant of KH presenting as an isolated skin lesion in adults.

References

  1. Zukerberg, LR, Nickoloff, BJ, Weiss, SW: Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 17:321, 1993.
  2. Tsang, WYW, Chang, JKC: Kaposi-like hemangioendothelioma: a distinctive vascular tumor of the retroperitoneum. Am J Surg Pathol 15:982, 1991.
  3. Enjolras, O, Wassef, M, Mazoyer, E et al: Infants with Kasabach Merritt syndrome do not have "true" hemangiomas. J Pediatr 130:631, 1997.
  4. Lyons,LL,North PE, Stoler, MH, Folpe, AH, Weiss, SW: Kaposiform hemangioendothelioma (KH) is histologically, immunohistochemically, and biologically distinct from common (juvenile) hemangioma (JH): A bi-institutional analysis of 33 cases. Mod Pathol, in press.
  5. Lai, FM, Allen, PW, Yuen, PM et al: Locally metastasizing vascular tumor: spindle cell, epithelioid or unclassified hemangioendothelioma. Am J Clin Path 96:660, 1991.